Medical conditions

In line with advice from the government, the following conditions are of concern - and you should discuss with your manager about working from home where possible or take special leave.

People at any age with a significant immunosuppression, as defined as:

  • Haematologic neoplasms: leukemias, lymphomas, myelodysplastic syndromes
  • Post-transplant: solid organ (on immunosuppressive therapy), haematopoietic stem cell transplant (within 24 months or on treatment for GVHD)
  • Immunocompromised due to primary or acquired immunodeficiency (including HIV infection)
  • Current chemotherapy or radiotherapy
  • High-dose corticosteroids (≥20 mg of prednisone per day, or equivalent) for ≥14 days
  • All biologics and most disease-modifying anti-rheumatic drugs (DMARDs) as defined as follows:
  • Azathioprine >3.0 mg/kg/day
  • 6-Mercaptopurine >1.5 mg/kg/day
  • Methotrexate >0.4 mg/kg/week
  • Prednisone >20 mg/day. If <14 days treatment, can resume work when treatment ceased
  • Tacrolimus (any dose)
  • Cyclosporine (any dose)
  • Cyclophosphamide (any dose)
  • Mycophenolate (any dose)
  • Combination (multiple) DMARDs irrespective of dose

The following chronic conditions are of concern in those 65 years and over, and Aboriginal and Torres Strait Islander people aged over 50:

  • Chronic renal failure
  • Coronary heart disease or congestive cardiac failure
  • Chronic lung disease (severe asthma (for which frequent medical consultations or the use of multiple medications is required), cystic fibrosis, bronchiectasis, suppurative lung disease, chronic obstructive pulmonary disease, chronic emphysema)
  • Poorly controlled diabetes
  • Poorly controlled hypertension

Please note: this information was last updated on 1 April 2020.

In line with advice from the government, the following conditions are of concern - and you should discuss with your manager about working from home where possible or take special leave.

People at any age with a significant immunosuppression, as defined as:

  • Haematologic neoplasms: leukemias, lymphomas, myelodysplastic syndromes
  • Post-transplant: solid organ (on immunosuppressive therapy), haematopoietic stem cell transplant (within 24 months or on treatment for GVHD)
  • Immunocompromised due to primary or acquired immunodeficiency (including HIV infection)
  • Current chemotherapy or radiotherapy
  • High-dose corticosteroids (≥20 mg of prednisone per day, or equivalent) for ≥14 days
  • All biologics and most disease-modifying anti-rheumatic drugs (DMARDs) as defined as follows:
  • Azathioprine >3.0 mg/kg/day
  • 6-Mercaptopurine >1.5 mg/kg/day
  • Methotrexate >0.4 mg/kg/week
  • Prednisone >20 mg/day. If <14 days treatment, can resume work when treatment ceased
  • Tacrolimus (any dose)
  • Cyclosporine (any dose)
  • Cyclophosphamide (any dose)
  • Mycophenolate (any dose)
  • Combination (multiple) DMARDs irrespective of dose

The following chronic conditions are of concern in those 65 years and over, and Aboriginal and Torres Strait Islander people aged over 50:

  • Chronic renal failure
  • Coronary heart disease or congestive cardiac failure
  • Chronic lung disease (severe asthma (for which frequent medical consultations or the use of multiple medications is required), cystic fibrosis, bronchiectasis, suppurative lung disease, chronic obstructive pulmonary disease, chronic emphysema)
  • Poorly controlled diabetes
  • Poorly controlled hypertension

Please note: this information was last updated on 1 April 2020.